Login / Signup

Cost-effectiveness analysis of trastuzumab emtansine (T-DM1) in treating HER-2 positive advanced breast cancer in Taiwan.

Lin-Chien WangChun-Nan KuoYu Ko
Published in: The breast journal (2020)
Keyphrases
  • metastatic breast cancer
  • epidermal growth factor receptor
  • positive breast cancer
  • glycemic control
  • type diabetes
  • metabolic syndrome
  • adipose tissue
  • breast cancer risk
  • tyrosine kinase